SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12957246
Source:
http://linkedlifedata.com/resource/pubmed/id/12957246
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006098
,
umls-concept:C0007112
,
umls-concept:C0030705
,
umls-concept:C0205474
,
umls-concept:C1274040
pubmed:issue
2
pubmed:dateCreated
2003-9-5
pubmed:abstractText
To evaluate 4-year biochemical outcomes for patients with prostate adenocarcinoma who underwent radioimmunoguided (Prostascint) permanent prostate brachytherapy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes
,
http://linkedlifedata.com/resource/pubmed/chemical/Palladium
,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen
,
http://linkedlifedata.com/resource/pubmed/chemical/Radioisotopes
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0360-3016
pubmed:author
pubmed-author:BeddarSamS
,
pubmed-author:ColussiValdirV
,
pubmed-author:DinchmanKurt HKH
,
pubmed-author:EllisRodney JRJ
,
pubmed-author:FuPingfuP
,
pubmed-author:KimEdwardE
,
pubmed-author:KinsellaTimothy JTJ
,
pubmed-author:ResnickMartinM
,
pubmed-author:SodeeBruceB
,
pubmed-author:SpirnakJohn PJP
,
pubmed-author:VertocnikAmyA
,
pubmed-author:YoungBenjaminB
,
pubmed-author:ZhouHangH
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
362-70
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12957246-Adenocarcinoma
,
pubmed-meshheading:12957246-Aged
,
pubmed-meshheading:12957246-Brachytherapy
,
pubmed-meshheading:12957246-Disease-Free Survival
,
pubmed-meshheading:12957246-Follow-Up Studies
,
pubmed-meshheading:12957246-Humans
,
pubmed-meshheading:12957246-Iodine Radioisotopes
,
pubmed-meshheading:12957246-Male
,
pubmed-meshheading:12957246-Middle Aged
,
pubmed-meshheading:12957246-Neoplasm Staging
,
pubmed-meshheading:12957246-Palladium
,
pubmed-meshheading:12957246-Prostate-Specific Antigen
,
pubmed-meshheading:12957246-Prostatic Neoplasms
,
pubmed-meshheading:12957246-Radioimmunodetection
,
pubmed-meshheading:12957246-Radioisotopes
,
pubmed-meshheading:12957246-Radiotherapy Dosage
,
pubmed-meshheading:12957246-Time Factors
pubmed:year
2003
pubmed:articleTitle
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma.
pubmed:affiliation
Department of Radiation Oncology, Aultman Hospital, Canton, OH 44708, USA. rje2@po.cwru.edu
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't